Impact of Time to Metastasis (Synchronous vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (ICI)-based Combinations

BACKGROUND: Metastatic renal cell carcinoma (RCC) can present as synchronous metastatic disease, where primary metastases are detected at the time of diagnosis, or metachronous disease, where metastases appear during follow-up after initial RCC diagnosis. The effect of time to metastasis on patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Meza, Luis, Li, Xiaochen, Zengin, Zeynep, Sayegh, Nicolas, Ebrahimi, Hedyeh, Tripathi, Nishita, Castro, Daniela, Mercier, Benjamin, Barragan-Carrillo, Regina, Li, Haoran, Chehrazi-Raffle, Alexander, Swami, Umang, Tripathi, Abishek, Agarwal, Neeraj, Maughan, Benjamin L, Pal, Sumanta K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Rapid Abstract Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445590/
http://dx.doi.org/10.1093/oncolo/oyad216.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445590/
http://dx.doi.org/10.1093/oncolo/oyad216.014

Ejemplares similares